Gen Surg SAQs · surgical-critical-care
Day-2 post-laparotomy oliguria — stage, bundle, fluids and dialysis triggers
Fellowship SAQ on postoperative AKI: KDIGO staging bands, bundle prevention with BigpAK-2 NNT 12, RELIEF fluids restraint with balanced crystalloids, delayed-RRT triggers with the AKIKI-2 floor, and kidney-health follow-up after mild AKI.
On this page
Study tools
Target exams
Write your answer
Saved on this device. No marking — you are the marker.
Model answer
(A) Stage 1 by both doors, high-risk by every factor, bundle by the trials (4 marks). Creatinine 1.8-fold sits in the 1.5–1.9 stage-1 band and 9 hours of urine below 0.5 mL/kg/h sits in the 6–12-hour stage-1 band — either alone defines AKI (0.3 mg/dL in 48 hours, 1.5-fold in 7 days, or 6-hour oliguria), and staging takes the worse of the two, which here agree.[1] He carries the full bedside risk set: older age, emergency major surgery, hypotension on pressors, vancomycin and contrast exposure — the cohorts' list (age, CKD, diabetes, heart failure, shock, nephrotoxins) applied to one patient.[4][5] Deploy the four-plank KDIGO bundle — haemodynamic optimisation with monitoring, volume restoration, nephrotoxin/contrast avoidance, no hyperglycaemia — quoting PrevAKI (55.1 versus 71.7%, ARR 16.6% single-centre) through BigpAK-2 (14.4 versus 22.3%, OR 0.57, NNT 12, multicentre, no harm).[18][19]
(B) Balanced liberal fluids, pressure floor with volume first, drugs reviewed (3 marks). Prescribe balanced crystalloids without overload and without RELIEF-style restriction (3.7 versus 6.1 L raised AKI 8.6 versus 5.0% with no survival gain) — balanced fluids beat saline on sepsis mortality (OR 0.84) and starch on AKI (OR 0.80) — holding MAP 65–70 per ESICM while giving volume before pressors, since both hypotension depth and cumulative noradrenaline independently predict AKI.[17][20][21] Switch vancomycin to AUC-guided dosing (less AKI than trough-guided, OR 0.625) and avoid further contrast and nephrotoxins per the bundle's third plank.[32][19]
(C) No dialysis today, triggers written, follow-up booked (3 marks). Without hyperkalaemia, acidosis, oedema, BUN above 112 or 72-hour oliguria, STARRT-AKI governs: accelerated RRT matched standard mortality (43.9 versus 43.7%) with more dependence and harm — and AKIKI shows half such patients never need dialysis — while ELAIN's early benefit stays quoted only as the contradicted single-centre outlier.[38][39][42] Write the five triggers and the AKIKI-2 floor (pushing past 72-hour oliguria/BUN 112 to BUN 140 gained nothing and raised death, HR 1.65).[40] Book focused kidney health assessment after discharge: even mild AKI carries adjusted 1-year mortality near trebled (HR 2.96), postoperative creatinine dips overestimate recovery, and follow-up is essential not optional.[10][4]
References14ShowHide
- [1]Kellum JA, et al. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care, 2013.PMID 23394211
- [4]Prowle JR, et al. Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Nat Rev Nephrol, 2021.PMID 33976395
- [10]O'Connor ME, et al. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg, 2017.PMID 28218392
- [18]Meersch M, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med, 2017.PMID 28110412
- [19]Zarbock A, et al. A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial. Lancet, 2025.PMID 41242333
- [20]Myles PS, et al. Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery. N Engl J Med, 2018.PMID 29742967
- [21]Tseng CH, et al. Resuscitation fluid types in sepsis, surgical, and trauma patients: a systematic review and sequential network meta-analyses. Crit Care, 2020.PMID 33317590
- [32]Abdelmessih E, et al. Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis. Pharmacotherapy, 2022.PMID 35869689
- [38]Bagshaw SM, Wald R, Adhikari NKJ, et al. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med, 2020.PMID 32668114
- [39]Gaudry S, et al. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. N Engl J Med, 2016.PMID 27181456
- [40]Gaudry S, et al. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet, 2021.PMID 33812488
- [42]Zarbock A, et al. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. JAMA, 2016.PMID 27209269
- [17]Joannidis M, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med, 2017.PMID 28577069
- [5]Zarbock A, et al. Update on Perioperative Acute Kidney Injury. Anesth Analg, 2018.PMID 30138176